Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females Citation: Doi Y, Hamano T, Yamaguchi O, et al. Blood Adv. 2025 Jul 8;9(13):3202-3212. PMID: 40239057; PMCID: PMC12246709.
The YODA Project